90 related articles for article (PubMed ID: 16393690)
1. The role of transforming growth factor beta signaling in messenger RNA stability.
Dibrov A; Kashour T; Amara FM
Growth Factors; 2006 Mar; 24(1):1-11. PubMed ID: 16393690
[TBL] [Abstract][Full Text] [Related]
2. Cellular signaling pathways affect the function of ribonucleotide reductase mRNA binding proteins: mRNA stabilization, drug resistance, and malignancy (Review).
Burton TR; Kashour T; Wright JA; Amara FM
Int J Oncol; 2003 Jan; 22(1):21-31. PubMed ID: 12469181
[TBL] [Abstract][Full Text] [Related]
3. Beta-Catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3'-UTR.
Lee HK; Jeong S
Nucleic Acids Res; 2006; 34(19):5705-14. PubMed ID: 17040897
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.
Verrecchia F; Mauviel A; Farge D
Autoimmun Rev; 2006 Oct; 5(8):563-9. PubMed ID: 17027893
[TBL] [Abstract][Full Text] [Related]
5. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
6. A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
Amara FM; Smith GM; Kuschak TI; Takeuchi TL; Wright JA
Biochem Biophys Res Commun; 1996 Nov; 228(2):347-51. PubMed ID: 8920917
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
8. Control of protein expression through mRNA stability in calcium signalling.
Misquitta CM; Chen T; Grover AK
Cell Calcium; 2006 Oct; 40(4):329-46. PubMed ID: 16765440
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
10. cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts.
Liu X; Sun SQ; Hassid A; Ostrom RS
Mol Pharmacol; 2006 Dec; 70(6):1992-2003. PubMed ID: 16959941
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 maintains the differentiation potential of nucleus pulposus cells in vitro: implications for cell-based transplantation therapy.
Tsai TT; Guttapalli A; Oguz E; Chen LH; Vaccaro AR; Albert TJ; Shapiro IM; Risbud MV
Spine (Phila Pa 1976); 2007 Mar; 32(5):495-502. PubMed ID: 17334282
[TBL] [Abstract][Full Text] [Related]
12. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
Zheng S; Chen A
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G113-23. PubMed ID: 16959952
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A
Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
[TBL] [Abstract][Full Text] [Related]
14. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.
Pohlers D; Beyer A; Koczan D; Wilhelm T; Thiesen HJ; Kinne RW
Arthritis Res Ther; 2007; 9(3):R59. PubMed ID: 17594488
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 generates a specific multicomponent extracellular matrix in human coronary SMC.
Schmidt A; Lorkowski S; Seidler D; Breithardt G; Buddecke E
Eur J Clin Invest; 2006 Jul; 36(7):473-82. PubMed ID: 16796604
[TBL] [Abstract][Full Text] [Related]
18. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
[TBL] [Abstract][Full Text] [Related]
19. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.
Noda D; Itoh S; Watanabe Y; Inamitsu M; Dennler S; Itoh F; Koike S; Danielpour D; ten Dijke P; Kato M
Oncogene; 2006 Sep; 25(41):5591-600. PubMed ID: 16636667
[TBL] [Abstract][Full Text] [Related]
20. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
